In this 21 st century cancer has become the second big reason for death next to heart attack in both developed and the developing countries. Worldwide, there are almost 2.1 million newly diagnosed breast cancer cases in 2018, accounting for 1 in 4 cancer cases among women. Triple Negative Human Breast Cancer is one of the types of human breast cancer. The plant extracts of Thevetia peruviana (Pers.) K. Schum. has been used against the Triple Negative Human Breast Cancer cell line MDA-MB-231 for the current experiment All the 5 parts (leaf, stem, flower, fruit and seed) had been selected for the experiment and the extracts of the various parts were made in hydroalcoholic solvent i.e. methanol: Water. Rajhans et al.; EJMP, 31(1): 64-69, 2020; Article no.EJMP.54621 65
INTRODUCTION
Presently, cancer has become the second big reason for death next to heart attack in both developed and the developing countries. Cancers originating from breast tissue, commonly from the inner lining of milk ducts or the lobules that supply milk in ducts are known as breast cancers. Worldwide, there are almost 2.1 million newly diagnosed breast cancer cases in 2018, accounting for 1 in 4 cancer cases among women [1] .
In different areas of breast, development of several types of tumors may take place. Any cancer test that is negative for the three main criteria i.e., the hormone estrogen, the hormone progesterone and a protein called HER-2 (Human Epidermal Growth Factor-2) is known as Triple Negative Human Breast Cancer (TNBC). The signs and symptoms of the TNBC is similar to the other breast cancer types. The three main symptoms of the TNBC (Triple Negative Breast Cancer) are (a) development of a lump or mass in the breast (b) breast pain or redness and (c) turning of the nipple inwards along with some discharge [2, 3] .
Over the years, use of natural products as anticancer agents is widely in practice and they are widely incorporated with ayurvedic and allopathic medicine [4] , as medicinal plants are renowned sources for phytochemicals with therapeutic values. Many studies have been done on bioactive plant products as anticancer, anti-inflammatory, and antimicrobial agents. One of the plant families i.e. Apocynaceae genus Thevetia and its other genera like Catharanthus, Nerium, Strophanthus, are well known for their anticancer activities because they are considered as a storehouse of numerous secondary metabolites especially cardiac glycosides [5, 6] . Thevetia peruviana (Pers.) K. Schum. commonly called yellow oleander has been traditionally used for the treatment of gastrointestinal and inflammatory diseases as well as heart failures and skin tumors [7, 8] . Studies have revealed the potent cytotoxic and antiproliferative effects of cardiac glycosides in several cancer cell lines, including breast, prostate, lung and renal cancers, melanoma, leukemia and neuroblastoma [9] . Therefore, present study aimed to investigate the role of Thevetia peruviana (Pers.) K. Schum as anticancer agents in triple negative breast cancer line.
MATERIALS AND METHODS

Plant Material
Collection of the plant material was done from the Gujarat University area. Different parts of the plant such as leaves, stems, flowers, fruits and seeds were collected. The parts were cleaned using water and kept for shade drying. After the drying process the parts were subjected to Soxhlet extraction. The solvent system taken was in the ratio of 70:30, methanol: Water (hydro-alcoholic). The qualitative screening of hydroalcoholic extracts of Thevetia peruviana (Pers.) K. Schum. (leaves, stems, flowers, fruits and seeds) was done for evaluating the presence of the secondary metabolites. The result of the phytochemical analysis exhibited that the plant is rich in phytochemicals like alkaloids, phenolic compounds, tannins, glycosides, cardiac glycosides, flavonoids, diterpenes, steroids and saponins [10] . On this basis of the phytochemical analysis it was further decided to evaluate the anticancer activities of the extracts of the plant parts.
Cell Lines and Cell Culture
Breast cancer cell line (MDA-MB-231) was used in the current study (NCCS Pune, India). It is a highly aggressive, invasive and poorly distinguished triple-negative breast cancer (TNBC) cell line. Cell lines were cultured in DMEM (himedia) supplemented with 10% (v/v) fetal bovine serum (Gibco). The cells were cultured at 37°C under a humidified atmosphere containing 5% CO 2 .
In vitro Cell Cytotoxicity Assay
The cell lines which were in exponential growth phase were washed, trypsinized and resuspended in complete culture media i.e., DMEM (Dulbecco's Modified Eagle Medium), 10% FBS (Fetal Bovine Serum), Penicillin (100 IU/ml), Streptomycin (100 μg/ml), Amphotericin-B (5 μg/ml), The cells were seeded at 2×10 4 cells/well in 96 well microtiter plate and incubated for 24 hrs. During this time period partial monolayer formation takes place.
Following these procedures, the cells were then exposed to the different extracts as mentioned above. The control set wells only received the maintenance medium. The plates were incubated at 37°C in a humified incubator with 5% CO 2 and 75% of relative humidity for a time period of 24 hrs. An inverted microscope (zeiss) was used to examine the morphological changes of the cells that were treated with the drugs. The examination was done at different time intervals. The cells serving as the control set were compared with the treated cells. At the end of 24 hrs, cellular viability was determined. After 24 hrs 10 μl of MTT was added and incubated for another 4 hrs. 100 μl of DMSO was further added to each well. Finally, the absorbance of the samples was measured using a microplate (ELISA) [Thermo Fisher Scientific] reader at the wavelength of 570 nm.
The % cell viability was calculated with the following formula: Cell viability % = Mean OD of wells receiving each plant extract dilution / Mean OD of control wells x 100
Determination of IC 50
IC 50 value is a measure of the efficacy of a substance in obstructing a specific biological or biochemical function. A line drawn from the 50 % value on the Y axis meets the curve and interpolate to the X axis. The X axis value gives the Log (concentration of the compound). The antilog of that value gives the IC 50 value. Percentage inhibition of compound against cell line was calculated using the following formula: % cell survival = (At -Ab)/ (Ac − Ab) *100 [11] .
where, At = Absorbance of Test, Ab= Absorbance of Blank (Media), Ac= Absorbance of control (cells) % cell inhibition = 100 − % cell survival
RESULTS
Assessment of the cytotoxic effect of T. peruviana hydroalcoholic extract on breast cancer line (MDA-MB-231) was performed by MTT assay (Fig. 1 ). An online tool has been used for calculating the IC50 value and for plotting the graphs.
The formula used here is Min + Max -Min 1 + (X/ IC 50 ) Hill coefficient A Sigmoid graph was obtained for all the 5 samples that had been examined for the presence of the anticancer activity using the MTT assay [12] .
IC 50 values indicate the concentration of the extract that inhibits the growth of 50% of the cell population. All extracts against breast cancer cell line, showed a cytotoxic effect with IC 50 values lower than 20 μg/ml. The strong anticancer activity was observed in flower and seeds extract which shows the IC 50 value of 0.007 and 0.002 μg/ml respectively at incubation for 24 hrs (Fig. 4  and 6 ). Leaves, fruits and stem extract shows the IC 50 value of 1.19, 1.464 and 5.474 μg/ml respectively (Figs. 2,3,5 ). 
DISCUSSION
The overall result suggests that the extract of the flowers and seeds are potent inhibitors against the MDA-MB-231 cell lines. In previous research works many researchers have reported that the extracts of the plant parts of Thevetia peruviana (Pers.) K. Schum. possess potential anticancer activities. Managit C et al. [13] reported that the ethanolic extract of flowers were effective against the HeLa cells. Silva AR et al. [14] Testified that the methanolic extract of the fruits possess anticancer potential against the human breast, colorectal, prostate and lung cancer cell lines. Save SA et al. [15] reported that from the twigs of the plant strong anticancer drugs had been formulated, which were effective against breast and lung cancer cell lines. In the current experiment the hydro alcoholic extract (70:30) (methanol: water) of the seeds have exhibited the best result against the human breast cancer cell line MDA-MB-231. The IC 50 value was 0.002. In the order next to the seeds the flowers with IC 50 value of 0.007 have shown anticancerous activity. In accordance to our finding Nesy EA [16] showed 100% cell death on cell lines DLA and EAC at a concentration of 1.2 mg/ml. [10] . The leaves, fruits and the stems have also exhibited anticancer activity with the IC 50 value of 
CONCLUSION
On the basis of the phytochemical analysis by Rajhans S et al. [10] and the above MTT assay result it can be concluded that the leaves, stems, flowers, fruits and seeds all the five parts of the plant possess anticancerous property. The best result was obtained from the flowers and the seeds, showing effective anticancerous property. The Triple Negative Human Breast Cancer can be treated via medicines. The chief constituents of the medicines will be the chemicals derived from the different parts of the plant Thevetia peruviana (Pers.) K. Schum.
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